Provisional session titles

ECNP audienceThe programme of the 37th ECNP Congress 2024 is currently under construction. Below you can already see some of the provisional session titles.

For the confirmed line-up for Keynote and Plenary Lectures, please click here.

Symposia

  • Novel vistas on the multiple links between mitochondria and mental health
  • Inflammation in depression: a bird’s eye view across the body and across the lifespan
  • Improving resilience as a therapeutic strategy: from neural mechanisms to pharmacological and artificial intelligence interventions
  • Predictive biomarkers for the therapeutic effects of classical psychedelic drugs
  • Implementing precision psychiatry in clinical practice: what are we waiting for?
  • Prescription digital therapeutics for mental health: where are we going?
  • Personalized psychopharmacology in neurodevelopmental disorders
  • Molecular pathways to accelerated aging in psychiatric disorders
  • The biology behind anorexia nervosa
  • Sex impact on pathophysiology of developmental brain disorders
  • Towards diagnostic digital health technologies in psychiatry
  • Can human genetics findings translate towards clinical practice in psychiatry?
  • Exploring the frontiers of pharmaco-fMRI: developments, applications, and challenges
  • Sleep endophenotypes in schizophrenia: from high-density EEG to neuronal reprogramming
  • In utero manipulations programming neurons for altered offspring behaviour
  • Pharmacotherapy in Down syndrome: from early brain development to adult-occurring neurodegeneration
  • The nutritional psychiatry of depression
  • Obsessive Compulsive Disorder: New insights on the biology and treatment
  • Treatment of ADHD across the lifespan: monitoring and predicting outcome
  • New Findings Symposium for Early Career Presenters (tba on May 2024)
  • New Medication Symposium (tba on May 2024)
  • Breaking Hot Topic Symposium (tba on May 2024)

Educational Update Sessions

  • Educational Update Session on bipolar disorder
  • Virtual reality for assessment and treatment in psychiatry: new findings and future directions
  • One mother, two lives: how perinatal interventions can change trajectories for both mothers and children.
  • Children and adolescents at high risk for psychosis and affective disorders: characterization and treatment
  • Catatonia: aetiology, presentation, assessment and treatment
  • Alcohol use disorders - personality dimensions and pharmacological treatments
  • Educational Update Session organised together with the EPA (European Psychiatric Association)